-
1 Comment
Vimta Labs Limited is currently in a long term uptrend where the price is trading 55.1% above its 200 day moving average.
From a valuation standpoint, the stock is 62.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.8.
Vimta Labs Limited's total revenue rose by 14.0% to $587M since the same quarter in the previous year.
Its net income has increased by 71.2% to $81M since the same quarter in the previous year.
Finally, its free cash flow grew by 195.5% to $172M since the same quarter in the previous year.
Based on the above factors, Vimta Labs Limited gets an overall score of 5/5.
| Industry | Diagnostics & Research |
|---|---|
| Exchange | NSE |
| CurrencyCode | INR |
| ISIN | INE579C01029 |
| Sector | Healthcare |
| Dividend Yield | 0.2% |
|---|---|
| Target Price | None |
| Market Cap | 23B |
| PE Ratio | 42.0 |
| Beta | 0.17 |
Vimta Labs Limited provides contract research and testing services in India and internationally. The company offers drug discovery, development, and drug life cycle management support services in the areas of preclinical research, clinical research, central lab, and analytical services for biopharmaceutical companies; preclinical research and testing services for medical device companies; and contract research and testing for agrochemical and specialty chemical companies. It also provides food testing and analytical development services to support manufacturers, processors, farmers, retailers, traders, exporters, and regulators; a testing laboratory for water, alcoholic, and non-alcoholic beverages; and clinical diagnostic services to patients, clinicians, hospitals, and central lab services to support clinical research studies. In addition, the company offers environmental regulatory services, such as impact assessments and post project monitoring, to various industries, including power, infrastructure, cement, oil and gas, and mining, etc.; and EMI/EMC testing for electronic and electrical products/components. It provides solutions to agriculture, biologics and biosimilars, home and personal care, medical device, specialty chemicals, food, clinical diagnostics, electrical and electronics, nutraceuticals, water and beverages, pharmaceuticals, crop care, environment, health and safety, and packaging industries. Vimta Labs Limited was founded in 1984 and is headquartered in Hyderabad, India.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for VIMTALABS.NSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
